Global /China /Healthcare /Biotechnology /688393
chevron_leftBack
Guangzhou LBP Medicine Science & Technology Co., Ltd. logo

Guangzhou LBP Medicine Science & Technology Co., Ltd.

688393
SSE: 688393 Delayed
24.60CNY 1%
3.64 USD
As of 18 June 2026, Guangzhou LBP Medicine Science & Technology Co., Ltd. has a market cap of $337.13M USD, ranking #17897 globally and #5509 in China. It ranks #1615 in the Healthcare sector, and #308 in the Biotechnology industry.
Global Rank
17897
Country Rank
5509
Sector Rank
1615
Industry Rank
308
Key Stats
Market Cap
$337.13MUSD
2.28B CNY
Enterprise Value
$289.61MUSD
1.96B CNY
Revenue (TTM)
$52.0MUSD
351.45M CNY
EBITDA (TTM)
$164.18KUSD
1.11M CNY
Net Income (TTM)
-$5.59MUSD
-37.79M CNY
EBITDA Margin
0.3%
Profit Margin
-11%
PS Ratio
6.5
PB Ratio
2.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Xiangting Cai open_in_new
Employees
779
Founded
2005
Website
gzlbp.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1% 7.3% 4.1% -13% 0.9% -18%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
688393
广州安必平医药科技股份有限公司 Class A
ISIN: CNE1000043R4
Shares Out.:
93.568M1 Shares Float: 93.549M2
TV:
SA:
YF:
GF:
BA:
MS:
24.60 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Guangzhou LBP Medicine Science & Technology Co., Ltd.

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner. It also provides immunohistochemistry products including automatic antigen repair instrument and automatic immunocytochemical staining machine, as well as conversional pathology equipment. The company was founded in 2005 and is based in Guangzhou, China.

Similar Companies

Industry: Biotechnology (China)
Name
Market Cap diff.
PE
$17.45B
136.71B HKD
5K%
25.3
$12.2B
95.58B HKD
4K%
22.1
$8.02B
54.23B CNY
2K%
34.4
$7.35B
49.69B CNY
2K%
-
1530
$7.08B
55.5B HKD
2K%
5.8
$6.74B
45.52B CNY
2K%
61.6
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
54K%
23.9
GILD
$159.92B
47K%
19.0
ARGX
$48.06B
41.39B EUR
14K%
39.9
$44.7B
68.19T KRW
13K%
35.5
LONN
$42.51B
33.71B CHF
13K%
37.2
CSL
$42.44B
60.27B AUD
12K%
29.3
chevron_leftBack